FundraiseDonate

OUR WORK

The Ovarian Cancer Research Foundation’s primary focus is to fund ovarian cancer research. Research remains the only solution to save women’s lives.

OCRF-FUNDED RESEARCH

The OCRF funds the most promising and innovative projects in order to save the most lives and remains the primary non-government funder of ovarian cancer research in Australia. With the generous support of donors, in the last five years alone we’ve been able to fund over $14 million of research.

OVER

$14,000,000

INVESTED IN RESEARCH SINCE 2016
panel Image
OVER

50

PROJECTS FUNDED SINCE 2016
panel Image

OCRF-FUNDED RESEARCH PROJECTS

Read about past and present OCRF-funded research projects. You can use the filters to more easily explore the projects. For example if you are interested in early detection, select this from the funding pillar drop down. Enjoy reading about the promising work your generosity supports.

2020-2023
Identifying new treatment options

Walter & Eliza Hall Institute of Medical Research

Funding Awarded: $150,000

Learn more
2019-2022
Therapeutic targeting of the leader cell population in ovarian cancer

Hudson Institute of Medical Research

Funding Awarded: $799,096

Learn more
2021-2024
Leveraging genomics to stop drug resistance

QIMR Berghofer Research Medical Institute

Funding Awarded: $494,958

Learn more
2022-2024
Targeting the tumour microenvironment to improve therapeutic response

La Trobe University, Olivia Newton John Cancer Research Centre

Funding Awarded: $299,826

Learn more
2022-2024
Detecting new therapeutic targets using functional genomics

Hudson Institute of Medical Research

Funding Awarded: $238,527

Learn more
2023-2026
A new treatment to increase immune response to ovarian cancer without side effects

Mater Research Institute, The University of Queensland

Funding Awarded: $500,486

Learn more
2023-2026
A treatment to increase immune response without side effects

The University of Queensland

Funding Awarded: $500,486

Learn more
2023-2026
Developing an early detection test using liquid biopsy analysis on circular RNAs

QIMR Berghofer Medica Research Institute

Funding Awarded: $852,343

Learn more
2019-2021
Targeting G9a to block metastasis

QIMR Berghofer Research Medical Institute

Funding Awarded: $187,760

Learn more
2020-2024 
Monitoring and intervention using extracellular vesicles

The University of Queensland

Funding Awarded: $60,000

Learn more
2018-2025 
OCRF-7: A Multivariate Index Assay

The University of Queensland

Funding Awarded: $570,383

Learn more
2009-2021 
The Active Ratio Test

Hudson Institute of Medical Research

Funding Awarded: $4,819,020

Learn more
2016-2023 
OCRF TISSUE BANK SOUTH AUSTRALIA

The University of Adelaide

Funding Awarded: $641,387

Learn more
2020-2021 and 2022-2023 
PRECISION MEDICINE FOR OVARIAN CANCER: DIRECTING TREATMENT OPTIONS

Hudson Institute of Medical Research

Funding Awarded: $401,966

Learn more
2016-2017 
EFFECT OF ASCITIC FLUIDS ON THE INHIBITION OF EGFR/HER2

University of Otago

Funding Awarded: $86,667

Learn more
2016-2019 
GRANULOSA CELL TUMOUR: SMAC MIMETICS TO TREAT GCT AND FOXL2 C134W

Hudson Institute of Medical Research

Funding Awarded: $545,061

Learn more
2020-2024 
GRANULOSA CELL TUMOUR: TOWARDS A NEW ERA

Hudson Institute of Medical Research

Funding Awarded: $44,250

Learn more
2016-2018 
BLOOD MARKERS OF OVARIAN CANCER

The University of Adelaide

Funding Awarded: $293,850

Learn more
2019-2021 
AUSTRALIAN CANCER RESEARCH FOUNDATION FACILITY FOR INNOVATIVE CANCER DRUG DISCOVERY

Bio21 Institute, University of Melbourne

Funding Awarded: $333,867

Learn more
2016-2023 
OCRF TISSUE BANK VICTORIA

Hudson Institute of Medical Research

Funding Awarded: $1,003,945

Learn more
2016-2018 
NOT A WHISPER BUT A ROR! TARGETING NOVEL RECEPTORS

University of New South Wales

Funding Awarded: $272,100

Learn more
2020-2023 
AUSTRALIAN CANCER RESEARCH FOUNDATION PROGRAM FOR RESOLVING CANCER COMPLEXITY AND THERAPEUTIC RESISTANCE

Walter & Eliza Hall Institute of Medical Research

Funding Awarded: $349,500

Learn more
2018-2020 
BLOOD PROTEIN BIOMARKERS

QIMR Berghofer Research Medical Institute

Funding Awarded: $236,172

Learn more
2020-2024 
A NEW RADIO IMAGING AGENT TO GUIDE TARGETED THERAPY FOR EPITHELIAL OVARIAN CANCER

Mater Research Institute, The University of Queensland

Funding Awarded: $60,000

Learn more
2016-2017 
KRT14 AS A NOVEL THERAPEUTIC TARGET

Hudson Institute of Medical Research

Funding Awarded: $260,192

Learn more
2020-2022 
DEVELOPING A COMBINATION THERAPY TARGETING TRIPLE-NEGATIVE BREAST CANCER AND HIGH-GRADE SEROUS OVARIAN CANCER

QIMR Berghofer Research Medical Institute

Funding Awarded: $265,590

Learn more
2016-2017 
FACTORS PREDICTING OVARIAN CANCER

Curtin University

Funding Awarded: $31,586

Learn more
2017-2020 
DNA METHYLATION FOR EARLY DETECTION

University of New South Wales

Funding Awarded: $380,500

Learn more
2017-2021 
REACTIVATING ANTI-TUMOUR IMMUNITY BY TARGETING THE N-MYC-LET7 AXIS

The University of Queensland

Funding Awarded: $489,564

Learn more

OVARIAN CANCER RESEARCH ARTICLES AND EXPLAINERS

Confused about CA125? Want to understand the latest research? Hear directly from researchers or dive deeper into topics like early detection or treatment by exploring our articles and explainers.

Latest Research News

Articles featuring news from OCRF-funded researchers in Australia, as well as news from around the world.

Read More
Research Explainer

Understand more about research areas, biomarkers and other relevant topics through our explainer articles.

Read More
Back to Our Work
Get the latest news, stories & updates.
Sign up to our newsletter
The Ovarian Cancer Research Foundation acknowledges the Traditional Custodians of the lands upon which we work, strive, and learn, the Wurrundjiri Woi wurrung and Bunorung Boon wurrung peoples of the Kulin Nation. We pay our respects to Elders past and present, and extend this respect to all Aboriginal and Torres Strait Islander peoples in Australia and beyond.